1. Home
  2. BNR vs ANTA Comparison

BNR vs ANTA Comparison

Compare BNR & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.02

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

ANTA

Antalpha Platform Holding Company Ordinary Shares

N/A

Current Price

$7.45

Market Cap

182.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
ANTA
Founded
2014
2022
Country
China
Singapore
Employees
N/A
113
Industry
Medical Specialities
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
179.7M
182.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
ANTA
Price
$9.02
$7.45
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.17
AVG Volume (30 Days)
10.1K
1.6K
Earning Date
06-05-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
$21.95
Revenue Next Year
N/A
$30.46
P/E Ratio
N/A
$19.77
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$6.25
52 Week High
$41.72
$15.65

Technical Indicators

Market Signals
Indicator
BNR
ANTA
Relative Strength Index (RSI) 20.79 39.74
Support Level $7.99 $6.80
Resistance Level $9.70 $9.81
Average True Range (ATR) 1.17 0.41
MACD -0.72 -0.15
Stochastic Oscillator 2.40 0.00

Price Performance

Historical Comparison
BNR
ANTA

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.

Share on Social Networks: